Improving the interface between biomaterials and the blood. The gene therapy approach.
Clowes
A W
AW
D000818:Animals; D001672:Biocompatible Materials; D001769:Blood; D001807:Blood Vessel Prosthesis / Q000295:instrumentation*; D017690:Cell Transplantation; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects / Q000293:injuries / Q000378:metabolism* / Q000473:pathology; D005342:Fibrinolysis / Q000235:genetics; D015870:Gene Expression; D015316:Genetic Therapy; D018056:Hemorheology; D006801:Humans; D017395:Plasminogen Activator Inhibitor 1 / Q000096:biosynthesis / Q000235:genetics; D012756:Sheep; D013499:Surface Properties; D010959:Tissue Plasminogen Activator / Q000096:biosynthesis / Q000235:genetics; D014945:Wound Healing
D001672:Biocompatible Materials; D017395:Plasminogen Activator Inhibitor 1; D010959:Tissue Plasminogen Activator